Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer

NCT07267247 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer (MeSH Term: Carcinoma, Non-Small-Cell Lung)
Drug-Related Side Effects and Adverse Reactions (MeSH Term)
Egfr Tyrosine Kinase Inhibitor
Cardiotoxicity

Interventions

DRUG: EGFR-TKI
OTHER: EGFR tyrosine kinase inhibitor

Sponsor

Taichung Veterans General Hospital